Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165 | 55 | 299 | 424 | 899 |
| Receivables | 3 | 58 | 59 | 74 | 56 |
| TOTAL | $244 | $203 | $440 | $575 | $1,044 |
| Non-Current Assets | |||||
| PPE Net | 4 | 5 | 6 | 6 | 6 |
| Other Non-Current Assets | 32 | 32 | 32 | 32 | 42 |
| TOTAL | $36 | $37 | $38 | $38 | $48 |
| Total Assets | $280 | $240 | $478 | $613 | $1,092 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,630 | 1,340 | 1,075 | 863 | 1,563 |
| Accrued Expenses | 857 | 857 | 857 | 857 | N/A |
| Other current liabilities | 9,277 | 8,373 | 7,510 | 6,663 | 5,870 |
| TOTAL | $12,616 | $11,172 | $10,044 | $8,961 | $8,010 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 602 | 602 | 602 | 578 | 577 |
| Other Non-Current Liabilities | 13,000 | 12,300 | 607 | 1,190 | 860 |
| TOTAL | $18,019 | $17,470 | $5,927 | $6,431 | $6,246 |
| Total Liabilities | $30,635 | $28,642 | $15,971 | $15,392 | $14,256 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21 | 21 | 21 | 21 | 20 |
| Common Shares | 6 | 265 | 260 | 6 | 255 |
| Retained earnings | -283,447 | -281,238 | -268,005 | -266,421 | -264,650 |
| Other shareholders' equity | -4 | -4 | -4 | -4 | -4 |
| TOTAL | $-30,355 | $-28,402 | $-15,493 | $-14,779 | $-13,164 |
| Total Liabilities And Equity | $280 | $240 | $478 | $613 | $1,092 |